XETRA - Delayed Quote EUR

BioNxt Solutions Inc. (BXT.DE)

0.3660
+0.0060
+(1.67%)
At close: June 13 at 5:35:35 PM GMT+2

Key Executives

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.
NameTitlePayExercisedYear Born
Mr. Wolfgang Probst Co-Founder, Interim CEO & Director 111.06k -- 1981
Mr. Hugh A. D. Rogers B.Sc., LL.B Co-Founder & Director 119.77k -- 1980
Dr. Raimar Lobenberg Ph.D. Co-Founder & Director 38.04k -- 1966
Dr. Florian A. Sahr Head of Project Management -- -- --
Dr. Wolfgang Wagner Head of Research & Development -- -- --

BioNxt Solutions Inc.

1820 Fir Street
Suite 270
Vancouver, BC V6J 3B1
Canada
780 818 6422 https://www.bionxt.com
Sector: 
Healthcare

Description

BioNxt Solutions Inc. engages in R&D and manufacturing of thin-film (sublingual) and skin patch (transdermal) drug delivery for neurological and autoimmune diseases, enhancing patient compliance and bioavailability. It offers diagnostic screening tests, and new active pharmaceutical production and evaluation, including precision transdermal and oral dissolvable drug formulations; oral health screening tests; and standardization and clinical evaluation of emerging active pharmaceutical ingredients for neurological applications. The company was formerly known as XPhyto Therapeutics Corp. and changed its name to BioNxt Solutions Inc. in November 2022. The company was incorporated in 2017 and is headquartered in Vancouver, Canada.

Corporate Governance

BioNxt Solutions Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

June 20, 2025 at 11:52 PM UTC - June 25, 2025 at 11:52 PM UTC

BioNxt Solutions Inc. Earnings Date

Recent Events

Related Tickers

27N0.DE CANNOVUM CANNABIS AG I
0.2250
-8.16%
 
B8FK.DE Biofrontera AG
2.4300
-2.41%
 
H6D0.DE Haleon plc
4.7070
-1.05%
 
ZOE.DE Zoetis Inc.
143.44
-0.83%
 
VIA.DE Viatris Inc.
7.85
-0.20%
 
SBX.DE SynBiotic SE
3.1650
+1.77%
 
HIGH.DE Cantourage Group SE
6.54
0.00%
 
APPH.DE Apontis Pharma AG
10.80
-10.37%
 
PSG.DE PharmaSGP Holding SE
28.80
+1.41%
 
DMP.DE Dermapharm Holding SE
35.30
-0.98%